TSLA
Tesla
-- 421.060 PLTR
Palantir
-- 80.550 NVDA
NVIDIA
-- 134.700 OXY
Occidental Petroleum
-- 47.130 AMD
Advanced Micro Devices
-- 119.210 
Update! Note the timeline
$Immuron (IMRN.US)$ secured guidance from the US Food and Drug Administration related to the development of its gastrointestinal product IMM-529 to treat infection caused by the bacteria Clostridioides difficile, according to a Thursday filing with the Australian bourse.
The feedback from the meeting will be used for an upcoming investigational new drug application by the first half of 2025 which will be followed by a phase two trial, the biopharmaceutical firm said in the filing.
The feedback from the meeting will be used for an upcoming investigational new drug application by the first half of 2025 which will be followed by a phase two trial, the biopharmaceutical firm said in the filing.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment